Does US FDA Need An Independent Commission To Analyze Its Pandemic Response?
Group of outside experts could help the agency determine the pandemic-inspired practices and regulatory changes to keep, former commissioner von Eschenbach says.
You may also be interested in...
Ken Frazier says advocates need to ensure governments continue investing in global biosecurity.
Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.
One of the lessons learned from the pandemic may be that virtual meetings can be used in place of an in-person session more often.